Controlling protein activity and localization is a key tool in modern biology. Mammalian 31 steroid receptor ligand-binding domains (LBDs) fusions have been used in a range of 32 organisms and cell-types to inactivate proteins of interest until the cognate steroid 33 ligand is applied. Here, we demonstrate that the glucocorticoid receptor LBD confers 34 ligand-gated control of a heterologous gene expression system (Q system) and the 35 DAF-16 transcription factor in C. elegans. These experiments demonstrate provide a 36 powerful tool for temporal control of protein activity, and will bolster existing tools used 37 to modulate gene expression and protein activity in this animal. 38
Introduction 39
The ability to temporally and spatially control gene expression and protein 40 activity/localization are essential tools in modern genetics. Heterologous systems, such 41
as Gal4/UAS have been widely used in Drosophila melanogaster, allowing researchers 42 exquisite control over the time and tissue in which the transgene is expressed (Brand 43 and Perrimon 1993). The Q system, which adapts the Neurospora crassa transcriptional 44 activator, QF, and its repressor, QS, to gene activation via de-repression of QS by 45 quinic acid, offers an additional system for transgene expression analysis, lineage 46 tracing, and mosaic analysis in mammalian cells and in fly models (Potter et al. 2010 ; 47 Riabinina et al. 2015) . Other methods to control gene expression include tissue-specific 48 expression of the Cre recombinase fused to the estrogen receptor ligand-binding 49 domain (Feil et al. 1996) , CRISPR interference and CRISPR activation (Qi et al. 2013 ; 50 Gilbert et al. 2013; 2014) , tetracycline-inducible gene regulation systems (TET 51 ON/OFF)(Gossen and Bujard 1992; Gossen et al. 1995) , and tags to stabilize or 52 destabilize proteins, in some cases in an inducible manner (Dohmen et al. 1994 ; In C. elegans, the most common method to induce gene expression is to fuse heat 57 shock promoters upstream of a gene of interest; following acute heat shock, gene 58 expression is robustly induced (Stringham et al. 1992 ). Modifications to this approach 59 include the FLP-OUT system (Voutev and Hubbard 2008) , and the HSF-1 system, 60
which allows for some tissue-specificity of gene induction (Bacaj and Shaham 2007) . 61 6 QF constructs and/or by expressing QF and QS using tissue-specific promoters, and 85 the system functioned effectively using single-copy transgenes (Wei et al. 2012) . Some 86 limitations of the system are that QS and QF have to be expressed constitutively, and 87 require a minimum of six hours for quinic acid to alleviate QS repression and allow 88 transgene induction, with complete restoration of transgene expression taking 24 hours; 89 this delay is not ideal for tightly controlling transgene induction in developmental 90 contexts, or during dynamic and rapid cellular events. 91 92 Using the ligand-binding domains (LBD) from mammalian steroid receptors permits 93 drug-inducible control of the Cre and Flp recombinases and the Gal4-UAS system 94 (Picard et al. 1988 ; Logie and Stewart 1995; Metzger et al. 1995 ; Kozlova and Thummel 95 2002) . We were interested in using steroid receptor LBDs would allow for both robust 96 repression of fused factors and rapid alleviation of this repression upon ligand addition. 97
We therefore wished to explore whether the human glucocorticoid receptor LBD could 98 be used to regulate two proteins in C. elegans: the QF transcriptional activator and the 99 DAF-16/FOXO transcription factor. 100 9 Catalog #D1383) were solubilized in ethanol, sterilized through a 0.2um filter, and 146 stored at 4°C in the dark until use. 147 148
Molecular Biology 149
For the extraction of total RNA, selected animals were placed in Trizol (Invitrogen; 150
Catalog #15596026) and subsequently lysed by rapid freeze cracking. The RNeasy 151 extraction kit (Qiagen; Catalog #74104) was used to remove contaminating genomic 152 DNA and isolate total RNA. The iScript cDNA synthesis Kit (Bio-Rad; Catalog #170-153 8891) was then used to synthesize cDNAs. To measure the levels of transcripts, master 154 mixes using cDNA templates, SsoAdvanced Universal SYBR Green Mix (Bio-Rad, 155
Catalog #1725270), and gene-specific primers were used. All reactions were performed 156 on the Bio-Rad CFX Connect Real-Time PCR Detection System instrument (Bio-Rad; 157
Catalog #1855200). The primers used in this study are listed in Supporting Information, 158
File S1, Table S2 . 159 160
Fluorescence Microscopy 161
All images were prepared for publication using Image J, Adobe Photoshop and Adobe 162
Illustrator. To score GFP expression, we transferred 10-20 mixed-staged animals to 163 NGM plates treated with vehicle or 100μM dex. Populations were cultivated at 25°C, 164 and fluorescence was assessed repeatedly every hour at 5X to 10X magnification using 165 the FSM25 Kramer Fluorescence Microscope, connected to an X-Cite 120Q fluorescent 166 light source. GFP and mCherry fluorescence were performed blind to the experimental 167 conditions, and at least three independent experiments were performed. 168
169
The remaining microscopy was performed on a Zeiss Axioplan 2 fluorescent 170 microscope attached to Xenon excitation lamps and green/red fluorescence filter sets. 171
Images were captured with the attached Hamamatsu Orca ER camera controlled by 172
Micro-Manager, an open-source microscopy software. For these experiments, animals 173 were paralyzed with 10mM levamisole, and mounted onto a 2% agar pads. For the 174 fluorescein-dexamethasone (F-dexa) experiments, mixed-staged animals were washed 175 three times for 15 minutes with M9 solution, soaked in an M9+0.05% gelatin solution 176 containing 1-100μM F-dexa, and rotated on the benchtop for two hours. Live 177 populations were then washed an additional three times with the M9 solution before 178
imaging. In populations expressing the hsp-16.48 promoter, mixed-staged animals were 179 gently washed off of NGM plates, and resuspended in M9 with vehicle or 100μM dex. A 180 30min, 33°C heat shock was performed in a thermocycler, and animals were incubated 181 at room temperature for an additional 3.5 hours on a bench top rotator before imaging. 182
To assess vulva morphology, populations were synchronized by extracting eggs from 183 gravid adults by alkaline lysis followed by hatching M9+0.05% gelatin for 24-48 hours at 184 25°C. Next, L1 hatchlings were released from the starvation-induced L1-diapause by 185 feeding, and subsequently grown to the mid-L4 larval stage. L4 larvae were then 186 washed off of plates, and treated with vehicle or 100μM dex for three hours rotating on a 187 bench top before imaging. Vulval morphology was assessed in mCherry positive 188 animals in late L4 larvae or young adults, at 16X-25X magnification. 189
190

Behavioral Assays 191
For measurements of behavioral adult quiescence, active young adults were transferred 192 into either vehicle or 100μM dex solutions in M9 buffer in a total volume of 100μl, and 193 then incubated on a rotator for two hours at room temperature. Animals were 194 transferred to an NGM plate seeded with OP50 E. coli for 30 minutes at room 195 temperature, and then individual adults were assessed for behavior. Behavioral 196 quiescence was defined by two criteria: 1) the absence of pharyngeal pumping for 60 197 secs, and; 2) the cessation of body movements for at least 30 secs, as previously 
Data Availability 215
Strains generated in this study will be available via the Caenorhabditis Genetics Center 216 (CGC) at the University of Minnesota-Twin Cities and/or through direct request to 217 J.D.W. The destination vectors described in this study (pGM32DEST, pGM34DEST, 218 and pGM48DEST) will be available via Addgene. 219
Results 220
A drug-inducible expression tool for C. elegans 221
To engineer a heterologous, drug-inducible gene expression system for C. elegans, we 222 modified the QF transcriptional activator by fusing the ligand-binding domain (LBD) from 223 the human glucocorticoid receptor (GRα; NCBI Gene ID: 2908) at the C-terminus (QF-224 GR; Figure 1A ). We chose the glucocorticoid receptor as C. elegans does not have any 225 clear orthologs (Antebi 2015) , and ligand binding by the GR LBD is very specific, 226
whereas estrogen receptor ligand-binding domain exhibits promiscuity (Eick et al. 227 2012) . QF-GR should be inactive until the synthetic, non-metabolized GR ligand 228 dexamethasone (dex) is added (Scherrer et al. 1993 ). QF-GR, was cloned into a 229 plasmid with a contiguous splice leader (SL) and an mCherry reporter, which marks 230 cells in which QF-GR is expressed. Though designed for Gateway cloning ( Figure S1A We first tested if the GR ligand, dex, could be effectively absorbed into live animals. We 238 used a fluorescein-dex (F-dexa) conjugate previously used to monitor the uptake of dex assessed uptake of F-dexa in wild-type (N2) animals, and in bus-8 mutants which have 242 a compromised cuticular barrier (Partridge et al. 2008 ). Mixed-stage populations were 243 cultured with increasing amounts of F-dexa for two hours and localization of F-dexa was 244 visualized using fluorescence microscopy. In both WT animals and bus-8 mutants, we 245 observed F-dexa exclusively in the pharyngeal and intestinal lumen in 97-100% 246 (n=1644) animals; notably, fluorescence was not detected in the epithelia of treated 247 animals ( Figure S1B ), and no fluorescence was observed in vehicle-treated populations 248 (n=419, *p<0.00001, Chi-square test). With increasing concentrations of F-dexa, 249 fluorescence was detected strongly and predominately within the intestinal lumen. F-250 dexa labeling of intestinal tissues was only observed at the highest tested concentration 251 (100μM). These results indicate that 100μM of F-dexa is sufficient for its uptake into C. 252 elegans intestinal cells, and further suggest that the intestine may be the tissue through 253 which dex is absorbed. 254 255
The GR LBD makes QF ligand-gated 256
We next asked whether dex and the GR LBD could gate the activity of the heterologous 257 QF-GR protein. We expressed QF-GR ubiquitously using the strong pro-1 promoter 258 (Hunt-Newbury et al. 2007), and a GFP reporter was included under control of the 259 4xQUAS element; a cistronic mCherry cassette was used to mark cells in which the 260 promoter was expressed. We observed induction of GFP 24 hours after cultivation with 261 100μM dex, but not after vehicle-treatment ( Figure 1B ). GFP expression was detected 262 in 86% (n=125) of animals expressing the mCherry reporter, as compared to 0.9% 263 (n=115) of vehicle-treated animals, and 0% (n=54) of animals with no drug treatment 264 (*p<0.001, Chi-square test). GFP was detected robustly and predominately in neuronal, 265 pharyngeal, and intestinal tissues ( Figure 1B) , and we also observed additional, modest 266 GFP expression in the hypodermis and muscles of other animals (data not shown); 267 however, we did not observe GFP nor mCherry expression in gonadal tissues. We did 268 notice muted, yet detectable expression of GFP in a pair of unknown head neurons in 269 both vehicle and dex-treated populations; this background pattern of expression was 270 consistent to that observed in animals expressing only the reporter gene ( Figure 1B T-Test) ( Figure 1C ). Using qPCR to measure GFP and mCherry transcript levels, we 297 observed a 3.5-fold increase in GFP levels in dex-treated animals, as compared to 298 vehicle-control animals ( Figure 1D ); mCherry mRNA levels did not change significantly 299 within the same dex and vehicle-treated populations. In contrast, after 30 minutes of 300 ligand exposure, we did not observe any significant changes in GFP transcript levels 301 ( Figure S1C ). GFP was detected initially in the nervous system, and most 302 predominately in unidentified tail neurons and the ventral cord. Notably, both the 303 percentage of GFP-positive animals, and the tissue-distribution of GFP expression 304 increased over time, with 80% of animals (n=38) expressing GFP in multiple tissues 305 after eight hours of cultivation on dex-treated plates, as compared to 0% (n=27) of 306 vehicle-treated populations (*p<0.001, T-Test). We similarly expressed QF-GR from an 307 alternative ubiquitous driver, eef-1A.1, and observed dex-specific GFP induction in 308 transgenic animals ( Figure S1C ). QF-GR expression from the eef-1A.1 promoter drove 309 significant reporter expression predominately in hypodermal, intestinal, and vulval 310 tissues after two hours of dex-exposure in 27% (n=26) of animals, as opposed to 0% 311 (n=22) of vehicle-treated animals (*p<0.04, T-Test) ( Figure S1D ). In contrast to 312 transgenics expressing QF-GR from the pro-1 promoter, we did not observe GFP in the 313 nervous system in eef-1A.1::QF-GR animals. Moreover, expression of GFP in the 314 intestinal, hypodermal, and vulva tissues appeared synchronously, and the intensity of 315 GFP fluorescence increased with longer exposures of dex (data not shown). Together, 316
these results indicate QF-GR permits ligand-gated transgene expression in most major 317 C. elegans tissues within two hours of dex exposure, and that promoter choice is an 318 important experimental consideration. 319 320
QF-GR allows tissue-specific transgene expression 321
Having established that the GR LBD inactivated QF and that dex exposure allowed for 322 QF activation, we next asked if QF-GR could drive tissue-specific transgene expression. 323
We expressed QF-GR in vulval and hypodermal tissues, using the tissue-specific egl-17 324 Transgenic animals were cultured in vehicle or 100μM dex for three hours, and ratio of 326 GFP-positive animals to mCherry-expressing animals was scored. We observed that 327 41% (n=26) of dex-treated egl-17p::QF-GR transgenics expressed GFP in the vulva, as 328 compared to 0% (n=25) of vehicle-treated animals (Figure 2A) . Similarly, hypodermal 329 expression of QF-GR from the atf-8 promoter resulted in 56% (n=41) of animals 330 expressing GFP with 100μM dex, as compared to 22% of vehicle-treated animals 331 (n=44) ( Figure 2B ). In both the atf-8p::QF-GR and eef-1A.1p::QF-GR transgenics, we 332 observed a higher proportion of vehicle-treated animals expressing GFP after three 333 hours of treatment compared to the pro-1p::QF-GR and egl-17p::QF-GR animals 334 ( Figure 2B and Figure S1D ). These results demonstrate that dex can regulate the 335 tissue-specific activity of QF-GR and its downstream reporter expression. Moreover, 336 these experiments reveal that particular tissue-expression of QF-GR may affect its 337 basal activity, as previously reported for ligand-activated GAL4 in Drosophila 338 Figure 2C ). We scored transgenic animals exposed for two hours to either vehicle or 348 100μM dex, and then assessed the behavioral quiescence of adult animals as 349 described in Methods. We observed an approximate 30-fold difference in behavioral 350 quiescence of dex-treated adults, as compared to vehicle-exposed adults (*p<0.005, T-351 Test). Specifically, 17% (n=181) of adults exhibited behaviors consistent with lin-3c-352 induced quiescence after a two hour treatment of dex, as compared to 0.4% (n=180) of 353 vehicle-treated animals ( Figure 2C ). These observations indicate that the forced 354 expression of lin-3/EGF can be achieved with dex-inducible QF-GR. 355
356
A powerful application of Gal4-UAS in Drosophila is for the conditional cell ablation by 357 expressing death genes, such as Reaper (White et al. 1994 ). In C. elegans, the peel-1 358 gene encodes a sperm-specific toxin, which destroys both germ and somatic cells in a 359 cell autonomous manner. Accordingly, ubiquitous overexpression of the peel-1 gene 360 results animal lethality (Seidel et al. 2011) . To test if our system could be used to 361 conditionally induce animal lethality, we attempted to induce multi-tissue expression of 362 peel-1 using pro-1p::QF-GR; however, we were unable to propagate the transgenic 363 lines due to toxicity of the arrays, even after multiple trials with various gene dosages 364 (data not shown). Therefore, we then asked if, alternatively, our system could be utilized 365 to drive cell death in a tissue-specific fashion, as was done in other organisms (Gerety Abnormal vulvas were observed in 39% (n=282) of dex-treated L4s, as compared for 371 14% (n=279) of vehicle-treated L4s ( Figure 2D ). Continued treatment with dex resulted 372 in lower brood sizes (data not shown), suggesting that damage to the vulva from the 373 peel-1 induction affected the overall fecundity of the population. Taken together, these 374 results demonstrate that our system permits drug-inducible transgene expression of 375 complex behavioral and morphological processes, and underscores that promoter 376 choice affects basal expression of QF-GR. 377 378
The QS repressor and quinic acid together restrain the activity of QF-GR 379
Neurospora QS protein inhibition of QF activity is relieved by addition of quinic acid (Wei 380 et al. 2012) . To test whether QS could inhibit the activity of QF-GR, we co-expressed 381 QF-GR and QS, and monitored QUAS::GFP reporter activity. As expected, we failed to 382 detect GFP fluorescence in animals cultured in either vehicle only or vehicle plus quinic 383 acid (n≥57) ( Figure 3B ). Following dex-treatment in the absence of quinic acid, we 384 observed GFP expression in only 0.9% and 1.0% (n≥85) of animals. However, when 385 transgenic animals were co-treated with both dex and quinic acid, we observed that 386 40% and 54% (n≥80) of animals expressed GFP ( Figure 3B ). Using qRT-PCR to assess 387 induction of transgene transcripts, after a two hour vehicle-treatment, the QF-GR 388 activator increased GFP levels approximately 28-fold above basal expression; addition 389 of 100μM dex increased GFP expression to 98-fold above basal expression ( Figure 3) . 390
As before, QS suppressed the expression of GFP mRNAs, as transcript levels were 391 only 1.7-fold higher in both vehicle and dex-treated populations relative to basal 392 expression ( Figure 3C ). After pre-treatment with quinic acid for approximately 24 hours, 393
we measured a small, but significant 2.3-fold increase in GFP transcript expression after 394 an acute, two hour dex-treatment. This dex-specific amplification was further intensified 395 after a 49 hour treatment with both dex and quinic acid. We identified an 11-fold 396 increase in GFP mRNAs in dex-treated animals, and only a 1.2-fold increase in GFP 397 transcripts in vehicle-treated animals, as compared to the basal activity from the 398 quas::GFP reporter. These data suggest that QS can repress transcriptional activity 399 even in the presence of dex, and that QS de-repression and dex activation provide dual 400 regulation, analogous to numerous bacterial operons that are under both negative and 401 positive control. 402 403
The GR-LBD adduct modulates DAF-16 and GFP activity in vivo. 404
Finally, we wished to determine whether the GR LBD could be more broadly used to 405 control the activity and localization of other C. elegans proteins. We fused the GR LBD 406 adduct to eGFP under the control of a heat-shock-inducible promoter (hsp-16.48), which 407 drives expression predominately in the muscle and hypodermis (Stringham et al. 1992) . 408
After a four hour treatment with 100μM dex, GFP expression was detected only in the 409 hypodermal nuclei of 100% (n=78) of animals; in contrast, GFP was visible in both the 410 cytoplasm and nucleus in 55% (n=94) of vehicle-treated animals ( Figure 4A ). This result 411 suggests that the GR LBD adduct may function to restrict localization of the linked 412 protein to the cytoplasm in the absence of ligand, and upon dex-binding, translocation to 413 the nucleus occurs more readily (Picard and Yamamoto 1987) . daf-2(-) mutants or wildtype animals (*p<0.03, T-Test). Together, these results suggest 432 that addition of the GR LBD adduct allows ligand-gated control of DAF-16 activity. 433
Conclusions 434
We found that the QF-GR system was sufficient to drive dex-inducible, tissue-specific 435 expression of a GFP reporter, the toxin gene peel-1, and ubiquitous expression of lin-436 3c. We further demonstrate that addition of a GR LBD onto DAF-16 was sufficient to 437 including the QS repressor and adding quinic acid to relieve repression, it took six hours 448 to detect transgene activity and 24 hours to fully de-repress the system (Wei et al. 449 2012) ; in contrast, QF-GR allows transgene induction within two hours (Figure 1 ). 450
Though we were able to observe mRNA induction following dex treatment up to 96-fold 451 over basal expression (Figure 3) , we did frequently observe background activity of QF-452 GR in vehicle treated animals, as discussed below. The QF-GR system should be 453 particularly useful for experiments where heat-shock induction of transgenes is not 454 possible or desirable (i.e., temperature sensitive mutations, physiological effects of 455 heat-shock, etc.), or when sustained transgene expression is required. For example, 456 using QF-GR rather than a heat-shock promoter to drive lin-3c would uncouple 457 behavioral lethargy from lin-3c overexpression and lethargy as a result from heat shock 458 (Van Buskirk and Sternberg 2007; Nelson et al. 2014) . 459
460
As a tool, the GR-LBD adduct should be improved and refined going forward. As 461 discussed above, we did frequently observe background activity of QF-GR in vehicle 462 treated animals. Additionally, the GR-LBD did not completely restrict the GR LBD::GFP 463 fusion to the cytoplasm, as would occur in mammalian cells (Picard and Yamamoto 464 1988) . Possible solutions include optimizing position of the GR-LBD relative to a tagged 465 protein, or including two LBD fusions on a construct. Notably, fusing Cre to two ER 466
LBDs in mice conferred tighter regulation and lower background with respect to 467 recombination at floxed alleles (Zhang et al. 1996; Casanova et al. 2002) . We also did 468 not detect transgene expression in the germline. All of our experiments were performed 469 using extrachromosomal arrays, which are frequently silenced in the C. elegans 470 germline. However, it is also possible that our failure to observe GFP expression in the 471 germline reflected a failure of dex to enter this tissue. New approaches to license 472 We observed higher basal activity of QF-GR when expressed using the atf-8 and eef-479
1A.1 promoters, as compared to the egl-17 and pro-1 promoters ( Fig 2B and Sup Fig  480   1C ). In Drosophila, progesterone receptor-gated Gal4 was shown to exhibit promoter-481 specific leakiness in the absence of the RU-486 ligand (Poirier et al. 2008) , and there is 482 leakiness dependent on the identity of the regulated transgene (Scialo et al. 2016) . It is 483 unclear what mechanisms drive leaky expression, but some possible explanations are 484 cell-specific differences in proteins that regulate steroid receptors in the presence or 485 absence of ligand, cell-or organism-specific differences in nuclear import/export, or that 486 dex and/or vehicle have unknown QF-GR-independent effects on worm physiology 487 (Picard et al. 1990; Freedman and Yamamoto 2004) . That being said, all of our 488 experiments utilized extrachromosomal arrays for expression of all transgenes; 489 therefore, we cannot eliminate the possibility that high basal expression from some of 490 the tested constructs was due to high gene dosage from these arrays. 491
492
We demonstrated that the GR LBD can be used to confer ligand-gating to three proteins 493 (QF, GFP, DAF-16), highlighting the potential broad utility of this tool in C. elegans to 494 regulate protein activity and/or localization. Many intensively studied transcription 495 
